as on December 12, 2025 at 4:01 pm IST
Day's High
5.36%
Upside
52 Week's Low
52 Week's High
11.88%
Downside
20.32%
Upside
as on December 12, 2025 at 4:01 pm IST
Market Cap
₹100.22 Cr
Return on Equity (ROE)
6.01
PE Ratio (TTM)
0Return on capital employed (ROCE)
8.98
Beta (LTM)
0.61
P/B Ratio
1.83
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
228
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Mercury Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 100.22 | 14.09% | 0.00 | 3 | 75 | |
| NA | 63.23 | 51.48% | 0.00 | -2 | 24 | |
| BUY | 10,633.70 | -1.17% | 0.00 | 181 | 724 | |
| NA | 33.09 | 102% | 0.00 | -1 | 50 | |
| BUY | 4,128.21 | 6.65% | 0.63 | 128 | 1,243 |
Search interest for Mercury Laboratories Ltd Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Mercury Laboratories Ltd.
Mercury Laboratories Ltd’s net profit jumped 228% since last year same period to ₹1.64Cr in the Q2 2025-2026. On a quarterly growth basis, Mercury Laboratories Ltd has generated 69.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Mercury Laboratories Ltd has declared dividend of ₹3.50 per share on 14 May 2025 - translating a dividend yield of 0.84%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 132.8% return, outperforming this stock by 123.2%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 73.66% of holdings in Sep 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 26.34% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 13.3% return, outperforming this stock by 27.0%
Price Dip
![]()
In the last 3 months, Mercury Labs stock has moved down by -2.6%
| Organisation | Mercury Laboratories Ltd |
| Headquarters | Vadodara |
| Industry | Pharmaceuticals |
| CEO | Divyakant Ramniklal Zaveri |
| E-voting on shares | Click here to vote |
Mercury Laboratories Ltd share price today stands at ₹835.2 as on at the close of the market. Mercury Laboratories Ltd share today touched a day high of ₹880 and a low of ₹835.2.
Mercury Laboratories Ltd touched a 52 week high of ₹1004.9 and a 52 week low of ₹736. Mercury Laboratories Ltd share price today i.e. is closed at ₹835.2, which is -16.89% down from its 52 week high and 13.48% up from its 52 week low.
Mercury Laboratories Ltd market capitalisation is ₹100.22 Cr as on .
To buy Mercury Laboratories Ltd shares, you need to follow these steps:
Mercury Laboratories Ltd trading volume is 39.00 as on . This means that 39.00 shares of Mercury Laboratories Ltd were bought and sold on the stock market during today's trading session.